2186 résultats correspondant à votre recherche

  • Clinical spectrum and features of activated phosphoinositide 3-kinase δ syndrome: A large patient cohort study

    Sven KRACKER, Anne DURANDY

    Source :

    J Allergy Clin Immunol. 2018

    2016 oct 16

    Pmid / DOI:

    27555459

  • Transmettre

    Stages et apprentissages

  • Improving the diagnostic efficiency of primary immunodeficiencies with targeted next-generation sequencing.

    Jérémie Rosain, Brigitte Bader-Meunier, Olivier Hermine, Felipe Suarez, Isabelle André, Vivien Beziat, Geneviève de Saint Basile, Jean-Pierre De Villartay, Sven KRACKER, Chantal LAGRESLE-PEYROU, Sylvain Latour, Frédéric Rieux-Laucat, Christine Bole, Patrick Nitschké, Alain Fischer, Despina Moshous, Bénédicte Neven, Alexandre Alcaïs, Jacinta Bustamante

    Source :

    J Allergy Clin Immunol

    2021 fév 1

    Pmid / DOI:

    32531373

  • Disease Evolution and Response to Rapamycin in Activated Phosphoinositide 3-Kinase δ Syndrome: The European Society for Immunodeficiencies-Activated Phosphoinositide 3-Kinase δ Syndrome Registry.

    Marina Cavazzana, Alain Fischer, Despina Moshous, Bénédicte Neven, Felipe Suarez, Sven KRACKER

    Source :

    Front Immunol

    2018 jan 1

    Pmid / DOI:

    29599784

  • Clinical spectrum and features of activated phosphoinositide 3-kinase δ syndrome: A large patient cohort study.

    Frédéric Rieux-Laucat, Sylvain Latour, Alain Fischer, Jean-Laurent CASANOVA , Anne DURANDY, Despina Moshous, Sven KRACKER

    Source :

    J Allergy Clin Immunol

    2017 fév 1

    Pmid / DOI:

    27555459

  • Topoisomerase 2β mutation impairs early B-cell development.

    Olivier Hermine, Alain Fischer, Anne DURANDY, Sven KRACKER

    Source :

    Blood

    2020 avr 23

    Pmid / DOI:

    32128574

  • From Dysgammaglobulinemia to Autosomal-Dominant Activation-Induced Cytidine Deaminase Deficiency: Unraveling an Inherited Immunodeficiency after 50 Years.

    Loïc CHENTOUT, Bertrand Boisson, Aurore POULIET, Anne DURANDY, Jean-Laurent CASANOVA , Sven KRACKER

    Source :

    J Pediatr

    2020 aoû 1

    Pmid / DOI:

    32423680

  • Successful Preclinical Development of Gene Therapy for Recombinase-Activating Gene-1-Deficient SCID.

    Chantal LAGRESLE-PEYROU, Marina Cavazzana

    Source :

    Mol Ther Methods Clin Dev

    2020 juin 12

    Pmid / DOI:

    32322605

  • NHP2 deficiency impairs rRNA biogenesis and causes pulmonary fibrosis and Høyeraal-Hreidarsson syndrome.

    Laëtitia Kermasson, Chantal LAGRESLE-PEYROU, Emmanuelle Ollivier, Alicia Fernandes, Jean-Pierre De Villartay, Patrick Revy

    Source :

    Hum Mol Genet

    2020 avr 15

    Pmid / DOI:

    31985013

  • Biosafety Studies of a Clinically Applicable Lentiviral Vector for the Gene Therapy of Artemis-SCID.

    Chantal LAGRESLE-PEYROU, Alain Fischer, Jean-Pierre De Villartay, Marina Cavazzana

    Source :

    Mol Ther Methods Clin Dev

    2019 déc 13

    Pmid / DOI:

    31720302